| Literature DB >> 35563760 |
Radouane Ouali1, Larissa Rezende Vieira2, Didier Salmon2, Sabrina Bousbata1.
Abstract
Understanding the development of Trypanosoma cruzi within the triatomine vector at the molecular level should provide novel targets for interrupting parasitic life cycle and affect vectorial competence. The aim of the current study is to provide new insights into triatomines immunology through the characterization of the hemolymph proteome of Rhodnius prolixus, a major Chagas disease vector, in order to gain an overview of its immune physiology. Surprisingly, proteomics investigation of the immunomodulation of T. cruzi-infected blood reveals that the parasite triggers an early systemic response in the hemolymph. The analysis of the expression profiles of hemolymph proteins from 6 h to 24 h allowed the identification of a broad range of immune proteins expressed already in the early hours post-blood-feeding regardless of the presence of the parasite, ready to mount a rapid response exemplified by the significant phenol oxidase activation. Nevertheless, we have also observed a remarkable induction of the immune response triggered by an rpPGRP-LC and the overexpression of defensins 6 h post-T. cruzi infection. Moreover, we have identified novel proteins with immune properties such as the putative c1q-like protein and the immunoglobulin I-set domain-containing protein, which have never been described in triatomines and could play a role in T. cruzi recognition. Twelve proteins with unknown function are modulated by the presence of T. cruzi in the hemolymph. Determining the function of these parasite-induced proteins represents an exciting challenge for increasing our knowledge about the diversity of the immune response from the universal one studied in holometabolous insects. This will provide us with clear answers for misunderstood mechanisms in host-parasite interaction, leading to the development of new generation strategies to control vector populations and pathogen transmission.Entities:
Keywords: Chagas disease; antiparasitic response; insect immunity; proteins expression; triatomines
Mesh:
Year: 2022 PMID: 35563760 PMCID: PMC9104911 DOI: 10.3390/cells11091449
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Figure 1(A) Venn diagram showing the distribution of the identified proteins of the hemolymph at 6 h and 24 h post-infection. Intersections display protein expression specificity to each condition (Table S1); (B) Representation of the distribution of total hemolymph proteome between intracellular and extracellular proteins. Extracellular proteins are recognized using OutCyte prediction tool either by the presence of a predicted signal peptide using the SignalP algorithm, transmembrane or potential unconventional protein secretions (UPS) from intracellular proteins. Numbers in brackets indicate the percentage of proteins in each category.
Figure 2Functional annotation of R. prolixus hemolymph proteins. The proteins have been classified according to their molecular function (A) and biological process; (B) according to Gene Ontology. Exhaustive information about the identified proteins is provided in Table S1.
Figure 3Circular histogram illustrating the distribution of R. prolixus secreted hemolymph proteins. The height of each bar is proportional to the LFQ intensity of expression of the corresponding protein, and each bar is related to the protein’s UniProt ID. Protein categories in the right panel are listed from the histogram clockwise.
Figure 4Bubble chart showing the differentially expressed proteins in R. prolixus hemolymph at 6 h and 24 h post-T. cruzi infection. Each bubble corresponds to a differentially expressed protein. x axis represents the fold change of protein expression, which is proportional to the bubbles size. y axis represents the log values of the intensity of protein expression.
Expression pattern of immunity related proteins identified in R. prolixus hemolymph.
| Immune Category | IDs | Protein Names | Fold Increase |
|---|---|---|---|
| Pattern recognition receptors (PRRs) |
| ||
| Peptidoglycan recognition receptor (PGRPs) | rpPGRP-LC/LAa |
| |
|
| |||
| rpPGRP-LC/LAb | |||
| Gram-negative binding proteins (GNBPs) | B8LJ39 | Beta-GRP |
|
|
| |||
|
| |||
|
| |||
| T1HGN7 | GH16 domain-containing protein |
| |
|
| |||
|
| |||
|
| |||
| T1I650 | GH16 domain-containing protein |
| |
|
| |||
|
| |||
|
| |||
| T1HU92 | ML domain-containing protein |
| |
|
| |||
|
| |||
|
| |||
| Mucins | T1HEN7 | Putative mucin |
|
|
| |||
|
| |||
|
| |||
| Antimicrobial peptides (AMPs) | |||
| Lysozymes | T1I5M5 | Lysozyme |
|
|
| |||
|
| |||
|
| |||
| A9LN32 | Lysozyme |
| |
|
| |||
| Prolixicins | B8QEI8 | Prolixin antimicrobial peptide |
|
|
| |||
|
| |||
|
| |||
| Attacins | T1I7V7 | Attacin_C domain-containing protein |
|
|
| |||
|
| |||
|
| |||
| Defensins | T1I7B0 | INVERT_DEFENSINS domain-containing protein |
|
|
| |||
| R4G8B6 | Putative defensin |
| |
|
| |||
| R4FNJ9 | Putative defensin a |
| |
|
| |||
|
| |||
| Diptericins | D6BJP6 | Diptericin |
|
|
| |||
|
| |||
|
| |||
|
| |||
| Glycine rich peptides | T1HS54 | Uncharacterized protein |
|
|
| |||
|
| |||
|
| |||
| R4G489 | Putative glycine-rich cuticle protein | ||
|
| |||
|
| |||
| A0A4P6DAB8 | Putative glycine-rich cuticle protein rhodnius neglectus | ||
|
| |||
|
| |||
| A0A4P6D8R0 | Putative glycine-rich cuticle protein rhodnius neglectus | ||
|
| |||
|
| |||
| Melanization | |||
| Prophenoloxidases | T1I7V8 | Phenoloxidase |
|
|
| |||
|
| |||
|
| |||
| A0A1B2G385 | Phenoloxidase 1 (EC 1.14.18.1) |
| |
|
| |||
|
| |||
|
| |||
| T1HW62 | Phenoloxidase (Fragment) |
| |
|
| |||
|
| |||
|
| |||
| A0A1B2G381 | Phenoloxidase 2 (EC 1.14.18.1) |
| |
|
| |||
|
| |||
|
| |||
| T1HW22 | Phenoloxidase (Fragment) |
| |
|
| |||
|
| |||
|
| |||
| Serine proteases | |||
| Clip-domain SP | T1HGB7 | CLIP domain-containing serine protease (EC 3.4.21.-) |
|
|
| |||
|
| |||
|
| |||
| R4FQA1 | CLIP domain-containing serine protease (EC 3.4.21.-) |
| |
|
| |||
|
| |||
|
| |||
| B8QQQ1 | CLIP domain-containing serine protease (EC 3.4.21.-) |
| |
|
| |||
|
| |||
|
| |||
| Protease inhibitors | |||
| Serpins | T1IF83 | SERPIN domain-containing protein |
|
|
| |||
|
| |||
|
| |||
| R4FJD2 | Putative serpin length |
| |
|
| |||
|
| |||
|
| |||
| T1I8D5 | SERPIN domain-containing protein |
| |
|
| |||
|
| |||
|
| |||
| R4FLP4 | Putative serpin length |
| |
|
| |||
|
| |||
|
| |||
| Cystatins | R4FP01 | Cystatin (Putative secreted protein) |
|
|
| |||
|
| |||
|
| |||
| T1I2F3 | Cystatin domain-containing protein |
| |
|
| |||
|
| |||
|
| |||
| R4G3U6 | Protein with 4 pacifastin inhibitor domains lcmii |
| |
|
| |||
|
| |||
|
| |||
| Detoxification | |||
| Superoxide dismutases | R4FMI6 | Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) |
|
|
| |||
|
| |||
|
| |||
| G1K083 | Superoxide dismutase (EC 1.15.1.1) (Fragment) | ||
|
| |||
|
| |||
| T1HRT6 | Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) |
| |
|
| |||
|
| |||
|
| |||
| A0A4P6D9T0 | Superoxide dismutase (EC 1.15.1.1) (Fragment) |
| |
|
| |||
|
| |||
|
| |||
| R4FPK6 | Superoxide dismutase (EC 1.15.1.1) (Fragment) |
| |
|
| |||
|
| |||
|
| |||
| Catalases | T1I0W4 | Catalase domain-containing protein (Fragment) |
|
|
| |||
| T1HV37 | Catalase domain-containing protein |
| |
|
| |||
| Peroxidases | T1I489 | Glutathione peroxidase (Fragment) |
|
|
| |||
|
| |||
|
| |||
| Glutathione S-transferases | T1HVN9 | Glutathione S-transferase domain containing protein |
|
|
| |||
|
| |||
|
| |||
| R4G417 | Putative glutathione S-transferase |
| |
|
| |||
|
| |||
|
| |||
| T1HUM1 | Putative glutathione S-transferase | ||
|
| |||
|
| |||
| Transglutaminases | T1HFP9 | TGc domain-containing protein (Fragment) |
|
|
| |||
|
| |||
|
| |||
| T1HFS7 | TGc domain-containing protein (Fragment) |
| |
|
| |||
|
| |||
|
| |||
| T1HFV3 | TGc domain-containing protein |
| |
|
| |||
| T1HFR5 | TGc domain-containing protein (Fragment) |
| |
|
| |||
|
| |||
|
| |||
| T1HFR9 | TGc domain-containing protein (Fragment) |
| |
|
| |||
|
| |||
|
| |||
| T1HFV2 | Uncharacterized protein |
| |
|
| |||
| T1I362 | Transglut_C domain-containing protein |
| |
|
| |||
|
| |||
|
| |||
| Transferrins | B8LJ43 | Transferrin |
|
|
| |||
|
| |||
|
| |||
| T1HAU6 | Melanotransferrin |
| |
|
| |||
|
| |||
|
| |||
| A0A4P6DAP6 | Putative transferrin isoform x4 (Fragment) |
| |
|
| |||
|
| |||
|
| |||
| Opsonization | A0A4P6D700 | Putative transmembrane protein of the immunoglobulin family of cell adhesion molecules (Fragment) |
|
|
| |||
|
| |||
|
| |||
| T1HCN4 | I-set domain-containing protein |
| |
|
| |||
|
| |||
|
| |||
| R4FJF3 | Putative c1q domain protein |
| |
|
| |||
Figure 5Western blot validation of defensins’ temporal expression profile in the hemolymph at 6 h and 24 h post-blood feeding and T. cruzi infection. The relative expression of defensins was calculated by normalizing the band intensity of defensins to the intensity of the total proteins signal. The results are expressed as the mean ± SEM (n = 3). Statistical significance is shown by * (* p ≤ 0.05 and ** p ≤ 0.01), calculated by unpaired t-test.
Figure 6Effect of blood ingestion and T. cruzi development on PO and PPO expression and activity in R. prolixus hemolymph at 6 h and 24 h post-challenge. (A) Profile plot representing the LFQ expression intensity of POs/PPOs isoforms under blood-fed and T. cruzi ingestion showing insignificant variation of the protein expression (n = 4); (B) Evaluation of PO and PPO activity in R. prolixus hemolymph from starved, blood-fed and infected insects. The results are expressed as the mean ± SEM (n = 3), and statistical significance is shown by * (* p ≤ 0.05, ** p ≤ 0.01) calculated by unpaired t-test.